医学
哮喘
特应性皮炎
变应原免疫治疗
过敏
皮肤病科
鼻腔给药
过敏原
免疫学
重症监护医学
免疫球蛋白E
抗体
作者
Chiara Trincianti,Maria Angela Tosca,Giorgio Ciprandi
标识
DOI:10.1080/17512433.2023.2225770
摘要
Allergic rhinitis (AR) is a widespread disease that can be associated with other conditions, including conjunctivitis, rhinosinusitis, asthma, food allergy, and atopic dermatitis. Diagnosis is based on the history and documentation of sensitization, such as the production of allergen-specific IgE, preferably using molecular diagnostics. Treatments are based on patient education, non-pharmacological and pharmacological remedies, allergen-specific immunotherapy (AIT), and surgery. Symptomatic treatments mainly concern intranasal/oral antihistamines and/or nasal corticosteroids.This review discusses current and emerging management strategies for AR, covering pharmacological and non-pharmacological remedies, AIT, and biologics in selected cases with associated severe asthma. However, AIT presently remains the unique causal treatment for AR.The management of allergic rhinitis could include new strategies. In this regard, particular interest should be considered in the fixed association between intranasal antihistamines and corticosteroids, probiotics and other natural substances, and new formulations (tablets) of AIT.
科研通智能强力驱动
Strongly Powered by AbleSci AI